Lucid, inc.: federal grants and contributions: 15 agreements; $1.9M value; 2 departments; 7 programs.
Assay record ASY-CA-0I2ZX9N0V7 · Cite as: Assay Systems, “Lucid, inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/lucid-inc/
Develop and launch a personalized music recommendation system that leverages deep reinforcement learning, biometric classification, and content-based filtering to provide a therapeutic solution for agitation within the Alzheimer’s and Dementia population.
LUCID, a Canadian digital health startup, and Emma Healthcare, a Korean SME specializing in advanced diagnostics, are collaborating to revolutionize neuropsychiatric care through the co-development of an AI-based music therapy solution. LUCID's BioMIR technology, which analyzes user data and predicts emotional and cognitive states to personalize digital music therapy, will be enhanced with Emma Healthcare's diagnostic capabilities and measurement expertise. This joint effort aims to optimize the effectiveness of the therapy offering by training it on diverse datasets from North American and As
This project aims to enhance LUCID’s AI-driven music therapeutic system for dementia care by integrating and developing scalable and portable AI modules. These advancements will enable personalized music interventions to scale to a larger population in the United States and in the Pacific region, with an initial focus on Japan and South Korea.
Development and launch of an individualized mental health solution that leverages deep reinforcement learning, contextual data, and individual preferences to optimize music therapy through a ubiquitous digital platform.
This project will test hypotheses and experiment with new mechanisms to design (or optimize) a repeatable and scalable business process, which may result in new business methods for the therapeutic music platform.
The Japan Keihanna partnership program will allow the form to integrate its novel sound tech (anxiety reducing intervention for patients) to TOA speakers which have novel directional capability for personalized sound for music or informational service.
The Project will support the assessment of data quality and data sources for AI project development. The project may also characterize and document aspects of data for AI and Data Governance.
This project will evaluate the potential of LUCID's AI-enabled digital platform to support personnel resilience and high-stress performance.
This project will measure feasibility for Implementation, public launch, in-use machine learning model experimentation, and optimization of LUCID's affective music recommendation system. .
Seek to improve and increase business development and partnership activities related to the research and development of music-based modalities to treat mental health disorders and associated symptoms.
In this project, we seek to research and strategize opportunities for licensing of LUCID technology and IP and Digital Music Therapy distribution, increasing firm visibility in domestic and international marketing, and unearth market insights for development and research team used to drive market success and prioritize the research and development pipeline.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
Participation in the Canadian AI solutions for health technologies (aging tech) co-innovation mission to Japan - December 2-6, 2024. A delegation led by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to explore the Japanese market and to develop international partnerships and potential project ideas under the Japan Program. In Partnership with the Trade Commissioner Service Canadian Technology Accelerator (TCS CTA), the Canadian delegation will also receive coaching and mentoring from industry leaders, support for their international business and mark
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.